Daily presurgery opioid use linked to poorer spine surgery outcomes

A study published in Spine examined the effects of preoperative opioid use on spinal deformity surgery outcomes.

Advertisement

Researchers studied 475 eligible patients from 18 surgical centers across the U.S., who underwent adult spinal deformity surgery between January 2008 and March 2015. They categorized patients’ self-reported opioid use as daily or nondaily. They also collected other patient data, such as baseline health characteristics and outcomes, preoperatively and postoperatively, at six weeks, one year and two years.

They found of the 425 patients included in the study, 44 percent self-reported daily preoperative opioid use. These daily users experienced more comorbidities, severe back pain and greater disability.

Additionally, daily users had a 70 percent higher likelihood of a prolonged length of stay in the hospital.

However, study authors did acknowledge the study’s limitations, which include the unreliability of self-reported opioid use, the inability to definitively say daily opioid use caused the poorer outcomes as well as the lack of information on patients’ specific opioid prescriptions.

More articles on opioids: 
How Geisinger cut opioid prescriptions in half: 3 things to know 
GOP lawmakers consider dropping Medicaid restrictions on opioid addiction therapy: 4 things to know 
Surgeon general calls on public to carry naloxone

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The 2 KPIs that drive readmissions — and how hospitals act on them in real time

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenter: Nik Rao, Dexur

Advertisement

Next Up in Patient Safety & Outcomes

Advertisement

Comments are closed.